Gene Silencing News and Research

RSS
Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Love hormone oxytocin linked to hypersexuality

Love hormone oxytocin linked to hypersexuality

Scientists develop method to reactivate tumor suppressor genes 'silenced' by cancer

Scientists develop method to reactivate tumor suppressor genes 'silenced' by cancer

Study reveals possible role of hormone oxytocin in hypersexual disorder

Study reveals possible role of hormone oxytocin in hypersexual disorder

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

Researchers develop a more precise version of CRISPR-Cas9 gene-editing system

Researchers develop a more precise version of CRISPR-Cas9 gene-editing system

Study explores why people at risk for Huntington's disease choose not to undergo genetic testing

Study explores why people at risk for Huntington's disease choose not to undergo genetic testing

Study describes vulnerability shared by large subset of cancer cell lines

Study describes vulnerability shared by large subset of cancer cell lines

Using gene therapy strategies to rejuvenate aging cells and treat osteoarthritis

Using gene therapy strategies to rejuvenate aging cells and treat osteoarthritis

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Shortage of specific gene 'silencing' molecules linked with pediatric low-grade gliomas

Shortage of specific gene 'silencing' molecules linked with pediatric low-grade gliomas

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

New study focuses on two-way gene switches controlling gene activity

New study focuses on two-way gene switches controlling gene activity

Antioxidant in green tea helps sneak therapeutic RNAs into cells

Antioxidant in green tea helps sneak therapeutic RNAs into cells

Penn researchers find common thread linking almost all TNR expansion diseases

Penn researchers find common thread linking almost all TNR expansion diseases

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease